Clinical Trials Browser

HER2-positive Locally Advanced Resectable Gastric Cancer × XELOX × Clear all

NCT06023758 2024-05-10

Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC

Phase 2 Recruiting

Gastrointestinal

HER2-positive Locally Advanced Resectable Gastric Cancer